Title |
Brain Cancer Radio-Pathomics for Predicting Heterogeneous Cytology
|
Institution |
MEDICAL COLLEGE OF WISCONSIN, MILWAUKEE, WI
|
Principal Investigator |
LAVIOLETTE, PETER
|
NCI Program Director |
Redmond
|
Cancer Activity |
Diagnostic Imaging
|
Division |
DCTD
|
Funded Amount |
$348,075
|
Project Dates |
06/09/2017 - 05/31/2022
|
Fiscal Year |
2017
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Cancer (100.0%)
Metastasis (50.0%)
Nuclear Magnetic Resonance Imaging (NMR) (50.0%)
|
Brain (100.0%)
|
Research Type |
Technology Development and/or Marker Discovery
|
Abstract |
"Abstract High-grade brain cancer (glioblastoma) is a devastating disease that very few patients survive long-term. The average life expectancy is 15 months, and throughout therapy patients undergo serial MR imaging for monitoring tumor response. It is not well understood how heterogeneity at the cellular and molecular levels affects the macroscopic imaging characteristics of these tumors. The long-term goal of this project is to provide imaging tools and biomarker integration strategies for individualizing glioblastoma treatment. The overall objective is to combine radiographic imaging with histopathological samples (i.e., radio-pathomics) to create and validate predictive tools for accurately defining tumor margins and spatial molecular profiles. Our central hypothesis is that microscopic glioblastoma cytological features and spatially dependent molecular profiles are reliably detectable and quantifiable with macroscopic MR imaging. Two specific aims will objectively test this hypothesis by first determining which microscopic tissue features contribute to distinct measurements with MR imaging, and second, determining the performance of machine learning algorithms for predictively mapping these heterogeneous histological features. !" |